Related references
Note: Only part of the references are listed.A novel DDS strategy, dual-targeting, and its application for antineovascular therapy
Yuki Murase et al.
CANCER LETTERS (2010)
Synergistic Targeting of alpha(v)beta(3) Integrin and Galectin-1 with Heteromultivalent Paramagnetic Liposomes for Combined MR Imaging and Treatment of Angiogenesis
Ewelina Kluza et al.
NANO LETTERS (2010)
Application of RGD-containing peptides as imaging probes for alphavbeta3 expression
Ingrid Dijkgraaf et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer
Hui Zhao et al.
JOURNAL OF DRUG TARGETING (2009)
Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide
Martina A. McAteer et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo
Juergen K. Willmann et al.
RADIOLOGY (2008)
Tumor targeting with RGD peptide Ligands-Design of new molecular conjugates for Imaging and therapy of cancers
Elisabeth Garanger et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2007)
Neuropilins in physiological and pathological angiogenesis
C. A. Staton et al.
JOURNAL OF PATHOLOGY (2007)
Enhanced solubility and stability of PEGylated liposomal paclitaxel: In vitro and in vivo evaluation
Tao Yang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers
Justin M. Saul et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Novel formulations of taxanes: a review. Old wine in a new bottle?
KL Hennenfent et al.
ANNALS OF ONCOLOGY (2006)
Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic
XB Xiong et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Liposomes targeted via two different antibodies: Assay, B-cell binding and cytotoxicity
K Laginha et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2005)
Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells
P Hölig et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2004)
A folate receptor-targeted lipid nanoparticle formulation for a lipophilic paclitaxel prodrug
PJ Stevens et al.
PHARMACEUTICAL RESEARCH (2004)
Targeting Stealth liposomes in a murine model of human small cell lung cancer
JN Moreira et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2001)
Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation
H Gelderblom et al.
EUROPEAN JOURNAL OF CANCER (2001)
Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis
R Binétruy-Tournaire et al.
EMBO JOURNAL (2000)
Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing water-soluble prodrugs of paclitaxel
M Ceruti et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Share Paper
